These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18032593)

  • 1. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.
    Clutterbuck EA; Oh S; Hamaluba M; Westcar S; Beverley PC; Pollard AJ
    Clin Vaccine Immunol; 2008 Feb; 15(2):182-93. PubMed ID: 18032593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
    Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
    Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
    Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J
    Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.
    Trück J; Thompson A; Morales-Aza B; Clutterbuck EA; Voysey M; Clarke E; Snape MD; Kelly DF; Finn A; Pollard AJ
    Vaccine; 2017 May; 35(20):2701-2708. PubMed ID: 28392142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine.
    Licciardi PV; Toh ZQ; Clutterbuck EA; Balloch A; Marimla RA; Tikkanen L; Lamb KE; Bright KJ; Rabuatoka U; Tikoduadua L; Boelsen LK; Dunne EM; Satzke C; Cheung YB; Pollard AJ; Russell FM; Mulholland EK
    J Allergy Clin Immunol; 2016 Jun; 137(6):1772-1779.e11. PubMed ID: 26825000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine booster in taiwanese toddlers.
    Shao PL; Lu CY; Chang LY; Huang FY; Lee CY; Hsueh PR; Huang LM
    J Formos Med Assoc; 2006 Jul; 105(7):542-9. PubMed ID: 16877233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain.
    Diez-Domingo J; Gurtman A; Bernaola E; Gimenez-Sanchez F; Martinon-Torres F; Pineda-Solas V; Delgado A; Infante-Marquez P; Liang JZ; Giardina PC; Gruber WC; Emini EA; Scott DA
    Vaccine; 2013 Nov; 31(46):5486-94. PubMed ID: 24004465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule.
    Trück J; Mitchell R; Jawad S; Clutterbuck EA; Snape MD; Kelly DF; Voysey M; Pollard AJ
    Pediatr Infect Dis J; 2017 May; 36(5):e130-e135. PubMed ID: 28027283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.
    van Westen E; Wijmenga-Monsuur AJ; van Dijken HH; van Gaans-van den Brink JA; Kuipers B; Knol MJ; Berbers GA; Sanders EA; Rots NY; van Els CA
    Clin Infect Dis; 2015 Aug; 61(3):342-9. PubMed ID: 25838290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants.
    Ruggeberg JU; Collins C; Clarke P; Johnson N; Sinha R; Everest N; Chang J; Stanford E; Balmer P; Borrow R; Martin S; Robinson MJ; Moxon ER; Pollard AJ; Heath PT
    Vaccine; 2007 Jan; 25(2):264-71. PubMed ID: 17070968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
    Blanchard Rohner G; Snape MD; Kelly DF; John T; Morant A; Yu LM; Borkowski A; Ceddia F; Borrow R; Siegrist CA; Pollard AJ
    J Immunol; 2008 Feb; 180(4):2165-73. PubMed ID: 18250423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children.
    Käyhty H; Ahman H; Rönnberg PR; Tillikainen R; Eskola J
    J Infect Dis; 1995 Nov; 172(5):1273-8. PubMed ID: 7594664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a booster dose of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine coadministered with the tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers: a randomized trial.
    Ruiz-Palacios GM; Huang LM; Lin TY; Hernandez L; Guerrero ML; Villalobos AL; Van der Wielen M; Moreira M; Fissette L; Borys D; Miller JM
    Pediatr Infect Dis J; 2013 Jan; 32(1):62-71. PubMed ID: 23076383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine.
    Harris SL; Finn A; Granoff DM
    Infect Immun; 2003 Jun; 71(6):3402-8. PubMed ID: 12761124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly.
    Baxendale HE; Keating SM; Johnson M; Southern J; Miller E; Goldblatt D
    Vaccine; 2010 Jul; 28(30):4763-70. PubMed ID: 20471437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.
    Sigurdardottir ST; Center KJ; Davidsdottir K; Arason VA; Hjalmarsson B; Elisdottir R; Ingolfsdottir G; Northington R; Scott DA; Jonsdottir I
    Vaccine; 2014 Jan; 32(3):417-24. PubMed ID: 24300594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine.
    Clutterbuck EA; Salt P; Oh S; Marchant A; Beverley P; Pollard AJ
    Immunology; 2006 Nov; 119(3):328-37. PubMed ID: 17067312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
    Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD;
    Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.
    Southern J; Borrow R; Andrews N; Morris R; Waight P; Hudson M; Balmer P; Findlow H; Findlow J; Miller E
    Clin Vaccine Immunol; 2009 Feb; 16(2):194-9. PubMed ID: 19091990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.